Skip to main navigation
Search
  • About
  • Discovery
  • Pipeline
  • Partnering
  • Investors & Media
  • Careers
  • About
  • Discovery
  • Pipeline
  • Partnering
  • Investors & Media
  • Careers
Location

Atreca, Inc.
500 Saginaw Drive
Redwood City, CA
94063-4750
United States

info@atreca.com
T +1.​650.595.2595
F +1.650.453.2410

  • Overview
  • News & Events
    • Press Releases
    • Event Calendar
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contact
  • Email Alerts
  • RSS Feeds
  • Print
  • Investor Contact
  • Investor FAQs
  • Search

Press Releases

Press Releases

Press

Atreca to Present at Upcoming Investor Conferences

May 19, 2022
PDF Version

READ MORE
Press

Atreca Reports First Quarter 2022 Financial Results and Recent Corporate Developments

May 11, 2022
PDF Version

READ MORE
Press

Atreca Announces Publication in PNAS: “Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101”

May 4, 2022
PDF Version

READ MORE
Press

Atreca to Present at Upcoming Virtual Investor Conferences

April 8, 2022
PDF Version

READ MORE
Press

Atreca Announces Expansion of Preclinical Pipeline

April 5, 2022
PDF Version

READ MORE
Press

Atreca to Host Virtual R&D Day on Tuesday, April 5, 2022

March 23, 2022
PDF Version

READ MORE
Press

Atreca to Participate in Cowen 42nd Annual Healthcare Conference

March 4, 2022
PDF Version

READ MORE
Press

Atreca Reports Fourth Quarter and Full-Year 2021 Financial Results and ATRC-101 Data Update

March 3, 2022
PDF Version

READ MORE
Press

Atreca to Report Fourth Quarter 2021 Results and Host Year-End Conference Call on March 3, 2022

February 24, 2022
PDF Version

READ MORE
Press

Atreca to Present Anti-SARS-CoV-2 Antibody Discoveries at Keystone Symposia Conference: Antibodies as Drugs

January 4, 2022
PDF Version

READ MORE
  • About
  • Discovery
  • Pipeline: Oncology
  • Partnering
  • Investors & Media
  • Careers
  • Contact
LOCATION

Atreca, Inc.
835 Industrial Rd., Suite 400
San Carlos, CA
94070
United States

info@atreca.com
T +1.​650.595.2595
F +1.650.453.2410

MEDIA/NEWS
  • Atreca to Present at Upcoming Investor Conferences May 19, 2022
  • Atreca Reports First Quarter 2022 Financial Results and Recent Corporate Developments May 11, 2022
  • Atreca Announces Publication in PNAS: “Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101” May 04, 2022

READ MORE

Copyright © 2022 Atreca, Inc. All rights reserved. | Site Map | Privacy | Terms of Use